Baird Holm’s 33rd Annual Health Law Forum
From 11/19/2021 8:15 am until 11/19/2021 3:15 pm
Baird Holm’s 33rd Annual Health Law Forum
Baird Holm’s 33rd Annual Health Law Forum is a value-added, educational offering for our clients and invited guests that provides comprehensive information about the complex regulatory environment faced by health care providers and administrators. This year, Baird Holm is excited to host its Health Law Forum in-person and online. Of course, the safety of our guests, staff, and attorneys remains our top priority and we will continue to look to the CDC and other authorities for guidance as the Forum draws closer. We will promptly notify you if our plans change.
Friday, November 19, 2021
Check-In: 7:45 a.m. – 8:15 a.m.
Welcome & Introduction: 8:15 a.m. – 8:30 a.m.
Event: 8:30 a.m. – 3:15 p.m.
10220 Regency Circle
Omaha, NE 68144
Safe Event Plan:
Please note that masks are required for everyone attending the in-person event.
Read about Baird Holm’s Safe Event Plan for the 2021 Health Law Forum.
Virtual Attendee Option:
If you select the “virtual” option for this forum, you will receive an email with a link to the livestream event, along with the presentation materials, in the days leading up to the actual Health Law Forum. Please note that the Health Law Forum will not be recorded for later access, so please plan to watch the event in real-time on Nov. 19.
As space is limited. Please register to attend in person or online by Friday, November 12, 2021.
If you have questions, please contact Kristen at firstname.lastname@example.org.
Continuing Education Credits:
This event is approved for the following continuing education credits:
- NE MCLE
- CCB CEU
- IA CLE
This event is pending approval for the following continuing education credits:
- NE CPE
7:45 – 8:15 a.m. | Check-In
8:15 – 8:30 a.m. | Welcome and Introductions
Abigail T. Mohs
8:30 – 10:45 a.m. | The Never-Ending COVID Question: Now What for the Health Care Industry?
John R. Holdenried (moderator),Vickie B. Ahlers, Scott S. Moore, Andrew D. Kloeckner, Michael W. Chase, Abigail T. Mohs, Erin E. Busch
The COVID-19 pandemic has created incredible challenges for healthcare providers over the past 20 months and counting. Many of the changes to our health care system won’t be temporary and will continue to have far-reaching implications once the pandemic is behind us. During an extended session, John Holdenried will moderate a panel consisting of Randy Stevenson, Andy Kloeckner, Michael Chase, Abby Mohs, and Erin Busch on these pandemic-related legal issues providers currently face or will face in the future. Topics include:
- Vaccine mandates for medical staff and employees
- Special privacy issues involving COVID, including exposure reporting
- Status of liability protections for COVID care
- Public meetings laws and pandemic-related updates
- Compliance issues after lapse of emergency declarations and waivers
- Fraud/recovery issues related to Provider Relief Funds and other COVID funding
- Telemedicine after COVID
- Late-breaking developments
10:45 – 11:00 a.m. | Break
11:00 – 11:45 a.m. | 340B Providers vs. Big Pharma: The Dire Reality
Barbara E. Person & Chandler C. Gall
Everyone in health care has heard about the threat to the 340B Drug Pricing Program. But not everyone has a strong footing in the basics of the Program, and what the big fuss is about. Barbra Person and Chandler Gall will present a primer on the 340B Program, identifying its original purpose and structure. Drug manufacturers have lodged complaints with 340B hospitals and against HRSA itself. Hospital associations have joined the conflict and there has been some judicial response. But 340B hospitals have been left with little direction, and have responded differently, depending upon their individual circumstances. Barbara and Chandler will provide an overview of the reasonable responses and sum up the remaining loose ends.
11:45 a.m. – 12:30 p.m. | Lunch
12:30 – 1:00 p.m. | The Latest Word
Panel of Baird Holm Attorneys
This session includes the always popular, fast-paced discussion of a variety of issues affecting health care organizations. This year’s panel of Baird Holm attorneys will cover recent topics including compliance issues, new and emerging laws, employee benefits issues, and several other health care law topics.
1:00 – 1:15 p.m. | Break
1:15 – 2:00 p.m. | The Surprising Implications of the No Surprises Act
Barbara E. Person & Kimberly A. Lammers
Breaking News: There are many surprises in the complex and confusing No Surprises Act! Some have referred to this Act as the 2021 version of HIPAA in that its web of regulatory requirements will affect providers, health plans, and patients and create many new compliance obligations. In that regard, the Act is much more than a simple prohibition on balance billing. In this session, Barbara Person and Kim Lammers will be unraveling the Act’s requirements and the regulations that have been issued to date. They will also discuss how the Nebraska and Iowa surprise billing laws are impacted by the new federal law. But the No Surprises Act isn’t the only billing-related regulatory activity we’ve seen in 2021. Barbara and Kim will also provide an update on recent developments related to pricing transparency laws and proposed penalties for noncompliance.
2:00 – 2:15 p.m. | Break
2:15 – 3:15 p.m. | The Surprisingly Hot HIPAA Topic: Revisiting Business Associate Rules in the age of Data Sharing
Vickie B. Ahlers & Michael W. Chase
Business associate – the status under HIPAA with so many implications and risks. These relationships have existed since the dawn of the Privacy Rule but continue to be tossed around and fumbled as much as a football. Vickie Ahlers and Michael Chase will discuss a wide range of issues related to business associates in 2021. When should you put a business associate agreement (BAA) in place and when should you not? What are the riskiest terms in BAAs these days (do you know what OCONUS stands for)? And lastly, but equally important, many business associates really want your data, but do you know what they plan to do with it, is their use of the data compliant with HIPAA, and what are you getting out of the deal? This session is packed with information on one of today’s surprisingly hot HIPAA topics.